Fracción de óxido nítrico exhalado en niños con asma y apnea obstructiva del sueño. Un estudio transversal realizado a gran altitud

Pantoja Gómez, Oscar Camilo

dc.contributor.author	Pantoja Gómez, Oscar Camilo
dc.date.accessioned	2024-06-28T11:35:03Z
dc.date.available	2024-06-28T11:35:03Z
dc.date.issued	2024-01-29
dc.identifier.uri	http://hdl.handle.net/10818/60703
dc.description	14 páginas	es_CO
dc.description.abstract	Introducción: La fracción exhalada de óxido nítrico (FeNO) es utilizada para el diagnóstico y fenotipificación del asma como biomarcador inflamatorio de la vía aérea. Existe escasa evidencia sobre su comportamiento en niños con apnea obstructiva del sueño (AOS). Realizamos este estudio con el fin de determinar si los niveles de FeNO se relacionan con la gravedad de la AOS o la coexistencia de asma y AOS en residentes a alta altitud.	es_CO
dc.format	application/pdf	es_CO
dc.language.iso	spa	es_CO
dc.publisher	Universidad de La Sabana	es_CO
dc.rights	Attribution-NonCommercial-NoDerivatives 4.0 Internacional	*
dc.rights.uri	http://creativecommons.org/licenses/by-nc-nd/4.0/	*
dc.subject.other	Óxido nítrico exhalado
dc.subject.other	Apnea Obstructiva del sueño
dc.subject.other	Asma
dc.subject.other	Polisomnografía
dc.title	Fracción de óxido nítrico exhalado en niños con asma y apnea obstructiva del sueño. Un estudio transversal realizado a gran altitud	es_CO
dc.type	bachelor thesis	es_CO
dc.type.hasVersion	publishedVersion	es_CO
dc.rights.accessRights	restrictedAccess	es_CO
dcterms.references	Hoyte FCL, Gross LM, Katial RK. Exhaled Nitric Oxide: An Update. Vol. 38, Immunology and Allergy Clinics of North America. W.B. Saunders; 2018. p. 573– 85.
dcterms.references	ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005. Vol. 171, American Journal of Respiratory and Critical Care Medicine. 2005. p. 912–30.
dcterms.references	Kovesi T, Kulka R, Dales R. Exhaled nitric oxide concentration is affected by age, height, and race in healthy 9- to 12-year-old children. Chest. 2008;133(1):169–75.
dcterms.references	Pignatti P, Visca D, Loukides S, Märtson AG, Alffenaar JWC, Migliori GB, et al. A snapshot of exhaled nitric oxide and asthma characteristics: experience from high to low income countries. Vol. 28, Pulmonology. Elsevier Espana S.L.U; 2022. p. 44–58.
dcterms.references	Brown DE, Beall CM, Strohl KP, Mills PS. Exhaled nitric oxide decreases upon acute exposure to high-altitude hypoxia. American Journal of Human Biology. 2006 Mar;18(2):196–202.
dcterms.references	Hemmingsson T, Horn A, Linnarsson D. Measuring exhaled nitric oxide at high altitude. Respir Physiol Neurobiol. 2009 Jul 31;167(3):292–8.
dcterms.references	Ghosh S, Kiyamu M, Contreras P, León-Velarde F, Bigham A, Brutsaert TD. Exhaled nitric oxide in ethnically diverse high-altitude native populations: A comparative study. Am J Phys Anthropol. 2019 Nov 1;170(3):451–8.
dcterms.references	Di Cicco M, Peroni DG, Ragazzo V, Comberiati P. Application of exhaled nitric oxide (FeNO) in pediatric asthma. Curr Opin Allergy Clin Immunol. 2021 Apr 1;21(2):151–8.
dcterms.references	Butler CA, Heaney LG. Fractional exhaled nitric oxide and asthma treatment adherence. Curr Opin Allergy Clin Immunol. 2021 Feb 1;21(1):59–64.
dcterms.references	for Healthcare Research A. The Clinical Utility of Fractional Exhaled Nitric Oxide (FeNO) in Asthma Management e [Internet]. Available from: www.ahrq.gov
dcterms.references	Cloutier MM, Baptist AP, Blake K V., Brooks EG, Bryant-Stephens T, DiMango E, et al. 2020 Focused Updates to the Asthma Management Guidelines: A Report from the National Asthma Education and Prevention Program Coordinating Committee Expert Panel Working Group. Journal of Allergy and Clinical Immunology. 2020 Dec 1;146(6):1217–70.
dcterms.references	J. Mariño J ENCMJ. Sociedad Española de Sueño. Tratado de Medicina del Sueño. Primera. España; 2015. 134–139 p.
dcterms.references	Gozal D. Sleep, sleep disorders and inflammation in children. Sleep Med. 2009 Sep;10(SUPPL. 1).
dcterms.references	Muzumdar H, Arens R. Physiological effects of obstructive sleep apnea syndrome in childhood. Vol. 188, Respiratory Physiology and Neurobiology. 2013. p. 370–82.
dcterms.references	Bikov A, Hull JH, Kunos L. Exhaled breath analysis, a simple tool to study the pathophysiology of obstructive sleep apnoea. Vol. 27, Sleep Medicine Reviews. W.B. Saunders Ltd; 2016. p. 1–8.
dcterms.references	Bucca C, Cicolin A, Guida G, Heffler E, Brussino L, Rolla G. Exhaled nitric oxide (F ENO) in non-pulmonary diseases. Vol. 6, Journal of Breath Research. 2012.
dcterms.references	Fortuna AM, Miralda R, Calaf N, González M, Casan P, Mayos M. Airway and alveolar nitric oxide measurements in obstructive sleep apnea syndrome. Respir Med. 2011 Apr;105(4):630–6.
dcterms.references	Finamore P, Scarlata S, Cardaci V, Incalzi RA. Exhaled breath analysis in obstructive sleep apnea syndrome: A review of the literature. Vol. 55, Medicina (Lithuania). MDPI AG; 2019.
dcterms.references	Carpagnano GE. Exhaled breath analysis and sleep. Vol. 7, Journal of Clinical Sleep Medicine. 2011.
dcterms.references	Zhang D, Xiao Y, Luo J, Wang X, Qiao Y, Huang R, et al. Measurement of fractional exhaled nitric oxide and nasal nitric oxide in male patients with obstructive sleep apnea. Sleep and Breathing. 2019 Sep 1;23(3):785–93.
dcterms.references	Kong DL, Qin Z, Shen H, Jin HY, Wang W, Wang ZF. Association of Obstructive Sleep Apnea with Asthma: A Meta-Analysis. Sci Rep. 2017 Dec 1;7(1).
dcterms.references	Trivedi M, El Mallah M, Bailey E, Kremer T, Rhein LM. Pediatric obstructive sleep apnea and asthma: Clinical implications. Pediatr Ann. 2017 Sep 1;46(9):e332– 5.
dcterms.references	Abreu AR, Alzoubaidi M, Bandyopadhyay A, Delrosso L, Ebben M, Kwon Y, et al. The AASM Manual for the Scoring of Sleep and Associated Events, Version 3 The AASM Manual for the Scoring of Sleep and Associated Events Rules, Terminology and Technical Specifications [Internet]. 2023. Available from: www.aasm.org.
dcterms.references	Alonso-Alvarez M, et al. Documento de consenso del síndrome de apneashipopneas durante el sueño en niños (versión completa). Arch Bronconeumol. 2011;47:2–18.
dcterms.references	5. Dweik RA, Boggs PB, Erzurum SC, Irvin CG, Leigh MW, Lundberg JO. An Official ATS Clinical Practice Guideline Interpretation of Exhaled Nitric Oxide Levels (FENO) for Clinical Applications. Am J Respir Crit Care Med [Internet]. 2011 May [cited 2023 Nov 30];184:602–15. Available from: www.atsjournals.org
dcterms.references	R Core Team (2023). R: A Language and Environment for Statistical Computing_. R Foundation for Statistical Computing, Vienna, Austria. [Internet]. [cited 2023 Nov 30]. Available from: <https://www.R-project.org/>.
dcterms.references	Foresi A, Leone C, Olivieri D, Cremona G. Alveolar-derived exhaled nitric oxide is reduced in obstructive sleep apnea syndrome. Chest. 2007;132(3):860–7.
dcterms.references	Przybyłowski T, Bielicki P, Kumor M, Hildebrand K, Maskey-Warzęchowska M, Frangrat A, et al. Exhaled Nitric Oxide in Patients with Obstructive Sleep Apnea Syndrome. Adv Respir Med. 2006 Mar 1;74(1):21–5.
dcterms.references	Depalo A, Carpagnano GE, Spanevello A, Sabato R, Cagnazzo MG, Gramiccioni C, et al. Exhaled NO and iNOS expression in sputum cells of healthy, obese and OSA subjects. J Intern Med. 2008 Jan;263(1):70–8.
dcterms.references	Gemicioglu B, Musellim B, Dogan I, Guven K. Fractional Exhaled Nitric Oxide (FeNo) in Different Asthma Phenotypes. Allergy & Rhinology. 2014 Jan;5(3):ar.2014.5.0099.
dcterms.references	Ricciardolo FLM, Sorbello V, Ciprandi G. A pathophysiological approach for FeNO: A biomarker for asthma. Vol. 43, Allergologia et Immunopathologia. Elsevier Doyma; 2015. p. 609–16.
thesis.degree.discipline	Facultad de Medicina	es_CO
thesis.degree.level	Especialización en Neumología	es_CO
thesis.degree.name	Especialista en Neumología	es_CO